UY38355A - Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisular - Google Patents
Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisularInfo
- Publication number
- UY38355A UY38355A UY0001038355A UY38355A UY38355A UY 38355 A UY38355 A UY 38355A UY 0001038355 A UY0001038355 A UY 0001038355A UY 38355 A UY38355 A UY 38355A UY 38355 A UY38355 A UY 38355A
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions containing
- pharmaceutical compositions
- solid pharmaceutical
- oleose
- pyrphenidone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
La presente invención describe composiciones farmacéuticas semisólidas conteniendo Pirfenidona, que ofrece ventajas sobre otras formas farmacéuticas de administración cutánea conocidas en el estado de la técnica, gracias a sus características de permeabilidad y absorción, que es útil en el tratamiento para la restauración de los tejidos que han sufrido pérdida o degradación de matriz extracelular dando como resultado la formación de arrugas o adelgazamiento de la piel
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2018010528A MX368750B (es) | 2018-08-31 | 2018-08-31 | Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY38355A true UY38355A (es) | 2020-03-31 |
Family
ID=69513965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001038355A UY38355A (es) | 2018-08-31 | 2019-08-29 | Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisular |
Country Status (17)
Country | Link |
---|---|
US (1) | US20210401989A1 (es) |
EP (1) | EP3842030A2 (es) |
JP (2) | JP7421558B2 (es) |
CN (1) | CN113056257A (es) |
AR (1) | AR116033A1 (es) |
AU (1) | AU2019329007A1 (es) |
BR (1) | BR112021003877A2 (es) |
CA (1) | CA3111314A1 (es) |
CL (1) | CL2021000509A1 (es) |
CO (1) | CO2021003927A2 (es) |
CR (1) | CR20210161A (es) |
EC (1) | ECSP21022187A (es) |
IL (1) | IL281142A (es) |
MX (1) | MX368750B (es) |
PE (1) | PE20212365A1 (es) |
UY (1) | UY38355A (es) |
WO (1) | WO2020046102A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007009796A (es) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
MX366086B (es) | 2017-08-15 | 2019-06-27 | Cell Therapy And Tech S A De C V | Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel. |
CN117653587A (zh) * | 2022-09-06 | 2024-03-08 | 南京迈诺威医药科技有限公司 | 一种含有吡非尼酮的局部外用制剂及其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02215719A (ja) | 1989-02-15 | 1990-08-28 | Yamauchi Akitomo | 線維化病変組織の修復並びに線維化病変の阻止剤 |
ATE224712T1 (de) | 1993-05-07 | 2002-10-15 | Solomon B Margolin | Zusammensetzungen und verfahren zur reparatur und vorbeugung fibrotischer verletzungen |
CA2322994A1 (en) * | 1998-03-17 | 1999-09-23 | Solomon B. Margolin | Topical antiseptic compositions and methods |
CH696420A5 (de) | 2002-09-13 | 2007-06-15 | Mepha Ag | Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung. |
CN101972225A (zh) * | 2010-10-13 | 2011-02-16 | 北京诚创康韵医药科技有限公司 | 一种含吡非尼酮的凝胶组合物 |
US20120208858A1 (en) | 2011-02-15 | 2012-08-16 | Allergan, Inc. | Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use |
CN102670600A (zh) | 2011-03-12 | 2012-09-19 | 赵海静 | 一种抑制瘢痕和促进创口愈合的医药产品,其制备方法和应用 |
MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
CA2905587A1 (en) | 2013-03-15 | 2014-09-18 | Medicis Pharmaceutical Corporation | Topical compositions of flunisolide and methods of treatment |
-
2018
- 2018-08-31 MX MX2018010528A patent/MX368750B/es active IP Right Grant
-
2019
- 2019-08-23 CA CA3111314A patent/CA3111314A1/en active Pending
- 2019-08-23 AU AU2019329007A patent/AU2019329007A1/en active Pending
- 2019-08-23 BR BR112021003877-9A patent/BR112021003877A2/pt unknown
- 2019-08-23 CN CN201980064402.9A patent/CN113056257A/zh active Pending
- 2019-08-23 JP JP2021537019A patent/JP7421558B2/ja active Active
- 2019-08-23 WO PCT/MX2019/000093 patent/WO2020046102A2/es active Application Filing
- 2019-08-23 US US17/272,144 patent/US20210401989A1/en active Pending
- 2019-08-23 CR CR20210161A patent/CR20210161A/es unknown
- 2019-08-23 EP EP19855904.9A patent/EP3842030A2/en active Pending
- 2019-08-23 PE PE2021000269A patent/PE20212365A1/es unknown
- 2019-08-29 UY UY0001038355A patent/UY38355A/es unknown
- 2019-08-29 AR ARP190102459A patent/AR116033A1/es unknown
-
2021
- 2021-02-26 CL CL2021000509A patent/CL2021000509A1/es unknown
- 2021-02-28 IL IL281142A patent/IL281142A/en unknown
- 2021-03-29 CO CONC2021/0003927A patent/CO2021003927A2/es unknown
- 2021-03-30 EC ECSENADI202122187A patent/ECSP21022187A/es unknown
-
2024
- 2024-01-12 JP JP2024002910A patent/JP2024029232A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3842030A2 (en) | 2021-06-30 |
MX368750B (es) | 2019-10-15 |
ECSP21022187A (es) | 2021-06-30 |
JP2022508418A (ja) | 2022-01-19 |
CL2021000509A1 (es) | 2021-07-19 |
AR116033A1 (es) | 2021-03-25 |
WO2020046102A2 (es) | 2020-03-05 |
IL281142A (en) | 2021-06-30 |
CO2021003927A2 (es) | 2021-07-30 |
AU2019329007A1 (en) | 2021-04-01 |
PE20212365A1 (es) | 2021-12-21 |
BR112021003877A2 (pt) | 2021-05-18 |
CA3111314A1 (en) | 2020-03-05 |
US20210401989A1 (en) | 2021-12-30 |
CR20210161A (es) | 2021-08-19 |
JP7421558B2 (ja) | 2024-01-24 |
WO2020046102A3 (es) | 2020-09-10 |
CN113056257A (zh) | 2021-06-29 |
JP2024029232A (ja) | 2024-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY38355A (es) | Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisular | |
CL2021000907A1 (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 (divisional de solicitud n° 01501-2020) | |
CL2020001312A1 (es) | Composiciones de cannabidiol y usos de las mismas. (divisional solicitud 201803425). | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
CO2020005887A2 (es) | Compuestos policíclicos como inhibidores alostéricos de shp2 | |
CL2021000415A1 (es) | Vesículas derivadas de lactobacillus paracasei y uso de las mismas | |
BR112015019440A8 (pt) | curativo regulável, kit, uso e método para fortalecimento da pele | |
CU20190101A7 (es) | Imidazopirimidinas diazabicíclicas sustituidas | |
CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
CO6400220A2 (es) | Derivados de sulfonamida | |
CL2019003398A1 (es) | Inhibidores pirazólicos de magl. | |
CL2016000544A1 (es) | Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel. | |
CL2017000845A1 (es) | Inhibidores de gingipaina de lisina | |
CU20110209A7 (es) | Composiciones adecuadas para el tratamiento tópico o infecciones fúngicas de la piel y unas | |
AR117730A1 (es) | Composición para relajación muscular | |
PE20130237A1 (es) | Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea | |
UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
CO2017003290A2 (es) | Composiciones y kits para desbridación enzimática y metodos de uso de los mismos | |
CL2021002650A1 (es) | Composición cosmética tópica y usos de la misma | |
BR112021009616A8 (pt) | Composição cicatrizante que compreende água eletrolisada e máscara de aplicação cutânea | |
BR112016026510A2 (pt) | Dispositivo e formulação para tratamento tópico da dor que afeta a área vulvar do órgão genital feminino | |
CO2019009020A2 (es) | Derivados de pirazol como inhibidores de bromodominio. | |
BR112016002580A2 (pt) | composição para tratamento antienvelhecimento de pele | |
ECSP21027009A (es) | Derivados de 4-pirazin-2-ilmetil-morfolina y su uso como medicamento | |
CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. |